menu search

Nih says pfizer's paxloid should be first treatment option for certain covid-19 patients

The National Institutes of Health on Wednesday updated its COVID-19 treatment guidelines for patients with mild to moderate forms of COVID-19 who are ...

January 20, 2022, 8:42 am

Nih says pfizer's paxloid should be first treatment option for certain covid-19 patients

The National Institutes of Health on Wednesday updated its COVID-19 treatment guidelines for patients with mild to moderate forms of COVID-19 who are ...

January 20, 2022, 8:42 am

Nih says pfizer's paxloid should be first treatment option for certain covid-19 patients

The National Institutes of Health on Wednesday updated its COVID-19 treatment guidelines for patients with mild to moderate forms of COVID-19 who are ...

January 20, 2022, 8:42 am

Moleculin biotech, inc. to present at the virtual investor 2022 top picks conference

HOUSTON, Jan. 20, 2022 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company wit...

January 20, 2022, 8:40 am

Moleculin biotech, inc. to present at the virtual investor 2022 top picks conference

HOUSTON, Jan. 20, 2022 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company wit...

January 20, 2022, 8:40 am

Moleculin biotech, inc. to present at the virtual investor 2022 top picks conference

HOUSTON, Jan. 20, 2022 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company wit...

January 20, 2022, 8:40 am

Novavax scores approval from australian regulator for covid-19 vaccine

Novavax Inc (NASDAQ: NVAX) said Wednesday that Australia's national drugs regulator has granted approval for its COVID-19 vaccine. What Happened: The...

January 20, 2022, 1:11 am

Novavax scores approval from australian regulator for covid-19 vaccine

Novavax Inc (NASDAQ: NVAX) said Wednesday that Australia's national drugs regulator has granted approval for its COVID-19 vaccine. What Happened: The...

January 20, 2022, 1:11 am

Novavax scores approval from australian regulator for covid-19 vaccine

Novavax Inc (NASDAQ: NVAX) said Wednesday that Australia's national drugs regulator has granted approval for its COVID-19 vaccine. What Happened: The...

January 20, 2022, 1:11 am

Why ziopharm oncology shares rose 10.5% on wednesday

The clinical-stage biotech saw a slight bounce-back from its lows of last week....

January 19, 2022, 5:35 pm

Why ziopharm oncology shares rose 10.5% on wednesday

The clinical-stage biotech saw a slight bounce-back from its lows of last week....

January 19, 2022, 5:35 pm

Why ziopharm oncology shares rose 10.5% on wednesday

The clinical-stage biotech saw a slight bounce-back from its lows of last week....

January 19, 2022, 5:35 pm

Valn stock alert: 4 things to know about the vaccine news sending valneva soaring

Valneva is picking up attention as the biotech firm is up more than 30% today. Will its vaccine candida...

January 19, 2022, 3:53 pm

Valn stock alert: 4 things to know about the vaccine news sending valneva soaring

Valneva is picking up attention as the biotech firm is up more than 30% today. Will its vaccine candida...

January 19, 2022, 3:53 pm

Valn stock alert: 4 things to know about the vaccine news sending valneva soaring

Valneva is picking up attention as the biotech firm is up more than 30% today. Will its vaccine candida...

January 19, 2022, 3:53 pm

U.s. ipo weekly recap: biotechs ring in the new year in a 4 ipo week

The IPO market kicked off the new year with three biotechs and an online home goods retailer, joined by four SPACs. Four SPACs went public led by Saga...

January 8, 2022, 11:36 pm

U.s. ipo weekly recap: biotechs ring in the new year in a 4 ipo week

The IPO market kicked off the new year with three biotechs and an online home goods retailer, joined by four SPACs. Four SPACs went public led by Saga...

January 8, 2022, 11:36 pm

U.s. ipo weekly recap: biotechs ring in the new year in a 4 ipo week

The IPO market kicked off the new year with three biotechs and an online home goods retailer, joined by four SPACs. Four SPACs went public led by Saga...

January 8, 2022, 11:36 pm

Cytokinetics: biotech that should be on your radar with several catalysts in 2022

Cytokinetics establishes partnership deal with Royalty Pharma for omecamtiv mecarbil and aficamten. Up to $450 million in total is expected for this p...

January 7, 2022, 7:51 pm

Cytokinetics: biotech that should be on your radar with several catalysts in 2022

Cytokinetics establishes partnership deal with Royalty Pharma for omecamtiv mecarbil and aficamten. Up to $450 million in total is expected for this p...

January 7, 2022, 7:51 pm


Search within

Pages Search Results: